Regulations.gov document
Considerations in Demonstrating Interchangeability With a Reference Product; Draft…
Notice · FDA-2017-D-0154 · posted Mar 15, 2017
Key facts
| Document ID | FDA-2017-D-0154-0007 |
|---|---|
| Title | Considerations in Demonstrating Interchangeability With a Reference Product; Draft Guidance for Industry; Availability; Extension of Comment Period |
| Document type | Notice |
| Subtype | Extension of Comment Period |
| Agency | FDA |
| Docket | FDA-2017-D-0154 |
| Posted | Mar 15, 2017 |
| Federal Register citation | 82 FR 13819 |
| FR document number | 2017-05102 |
| Comment period opens | Mar 15, 2017 |
| Comments due | May 20, 2017 |
| Effective date | Mar 15, 2017 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: